Savant Capital LLC raised its position in CVS Health Corporation (NYSE:CVS) by 13.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,767 shares of the pharmacy operator’s stock after buying an additional 1,148 shares during the period. Savant Capital LLC’s holdings in CVS Health Corporation were worth $935,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of CVS. Bank of Montreal Can acquired a new position in shares of CVS Health Corporation during the second quarter worth approximately $438,948,000. Nordea Investment Management AB raised its position in shares of CVS Health Corporation by 61.3% in the second quarter. Nordea Investment Management AB now owns 11,644,431 shares of the pharmacy operator’s stock worth $1,114,838,000 after buying an additional 4,423,216 shares during the period. Credit Agricole S A raised its position in shares of CVS Health Corporation by 112.8% in the first quarter. Credit Agricole S A now owns 2,492,231 shares of the pharmacy operator’s stock worth $258,521,000 after buying an additional 1,320,987 shares during the period. NN Investment Partners Holdings N.V. acquired a new position in shares of CVS Health Corporation during the first quarter worth approximately $125,795,000. Finally, State Street Corp raised its position in shares of CVS Health Corporation by 2.4% in the first quarter. State Street Corp now owns 44,552,112 shares of the pharmacy operator’s stock worth $4,621,391,000 after buying an additional 1,023,799 shares during the period. Institutional investors own 80.95% of the company’s stock.
CVS Health Corporation (NYSE:CVS) traded up 0.91% during trading on Friday, hitting $88.80. 6,705,822 shares of the company traded hands. The company’s 50 day moving average is $90.11 and its 200-day moving average is $96.45. The stock has a market capitalization of $94.68 billion, a PE ratio of 20.43 and a beta of 0.83. CVS Health Corporation has a 52 week low of $85.41 and a 52 week high of $106.67.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The business had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. During the same quarter in the previous year, the business posted $1.19 earnings per share. The business’s revenue was up 17.6% compared to the same quarter last year. Analysts predict that CVS Health Corporation will post $5.86 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th will be given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend is Thursday, October 20th. CVS Health Corporation’s dividend payout ratio (DPR) is 39.08%.
CVS has been the topic of a number of recent research reports. Morgan Stanley lowered shares of CVS Health Corporation from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $111.00 to $104.00 in a report on Monday, June 20th. Credit Suisse Group AG restated an “outperform” rating and issued a $110.00 target price (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, October 4th. Robert W. Baird dropped their target price on shares of CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating on the stock in a report on Monday, October 3rd. Leerink Swann restated an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Finally, Jefferies Group restated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. Five investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $112.40.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.